Abingdon Health's Series C Round

Abingdon Health raised a round of funding on July 13, 2016. Investors include Touchstone Innovations.

Abingdon Health is commercializing Seralite‐ FLC Serum and Seralite– FLC Urine. These assays allow for the rapid quantitative measurement of kappa (K) and lambda (λ) immunoglobulin free light cha…

Articles about Abingdon Health's Series C Round: